4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-016645
Chief Legal Officer & Corp Sec sold 2,090 shares at $3.26 ($6,813)
- Chief Legal Officer & Corp Sec acquired 2,090 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Derek M Chief Legal Officer & Corp Sec | 2026-03-06 | Option exercise 10b5-1 | +2,090 | $1.85 | $3,867 | 176,089 | D |
| Meisner Derek M Chief Legal Officer & Corp Sec | 2026-03-06 | Sale 10b5-1 | −2,090 | $3.26 | $6,813 | 173,999 | D |
| Derivatives | |||||||
| Meisner Derek M Chief Legal Officer & Corp Sec | 2026-03-06 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −2,090 | 71,048 | D | ||
| Open-market sales · 2,090 sh · avg $3.26 · $6,813 | |||||||
Loading xslF345X05/wk-form4_1773193523.xml…